Mounjaro 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FD2VP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,475
Award facts
- Contract value 100% obligated
- $18,475.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,475.15 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 ml pen injections on January 20, 2026, with an ultimate completion date of January 21, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor that provides critical medical commodities to federal agencies, particularly the Department of Defense and related healthcare systems. The SPE2DX IDC encompasses a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. As a non-set-aside contract awarded through open competition, this delivery order demonstrates the contractor's capability to meet federal procurement requirements for essential pharmaceutical products supporting military treatment facilities and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FD2VP?
SPE2DR26FD2VP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FD2VP worth?
The government has obligated $18,475 on SPE2DR26FD2VP.
Is contract SPE2DR26FD2VP an order under another contract?
Yes. SPE2DR26FD2VP is a delivery order under SPE2DR25D2203, an indefinite delivery contract.
Was contract SPE2DR26FD2VP competed?
The extent of competition for SPE2DR26FD2VP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award